Atena Journal of Public Health publishes high-quality research articles that can advance public health policies and outcomes. Further details on how to submit to the journal, are provided below. If you require further clarification, the journal’s editorial staff will be pleased to help (email firstname.lastname@example.org).
Manuscripts must be solely the work of the author(s) stated, must not have been previously published elsewhere, and must not be under consideration by another journal. Atena Journals support the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, issued by the International Committee of Medical Journal Editors (ICMJE Recommendations), and the Committee on Publication Ethics (COPE) Core Practices. We follow COPE’s guidelines.
HOW TO SUBMIT YOUR PAPER
Manuscript submission to Atena Journals is free. There are not article processing fees.
Manuscripts should be submitted online via the Atena Journals’ online submission and peer review website (OJS) at https://atenajournals.com/index.php/ajph
• Simply log on and follow the on-screen instructions for all submissions
• If you have not used it before, you will need to register first.
• If you have any technical problems or questions, please contact our dedicated author support: email@example.com
Accepted File Formats
Authors must use the Microsoft Word template to prepare their manuscript. Using the template file will substantially shorten the time to complete copy-editing and publication of accepted manuscripts. Accepted file formats are:
• You should upload your covering letter at the “Comments to Editor” stage of the online submission process
• Use the covering letter to explain why your paper should be published in Atena Journal of Public Health
• Authors are strongly encouraged to suggest in the covering letter possible reviewers for their manuscript. Please include the name, affiliation and email address of the reviewers suggested. The reviewers proposed should hold no conflicts of interest with the authors and should be experts in the field of the submitted paper
First submissions to Atena Journal of Public Health should include:
1 Covering letter
3 Protocols and CONSORT details for randomised controlled trials (see Articles)
STATEMENTS, PERMISSIONS, AND SIGNATURES
Authors and contributors
• Designated authors should meet all four criteria for authorship in the ICMJE Recommendations
• All authors, and all contributors (including medical writers and editors), should specify their individual contributions at the end of the text
• We encourage collaboration and coauthorship with colleagues in the locations where the research is conducted
• When choosing coauthors, we ask lead authors to be mindful of the benefits of diversity in authorship and to consider inviting coauthors who reflect diversity in every sense, including (but not limited to) background, career-stage, gender, geography, and race
• Please include written consent of any cited individual(s) noted in acknowledgments or personal communications
Declaration of interests
• A conflict of interest exists when professional judgement concerning a primary interest (such as patients’ welfare or validity of research) may be influenced by a secondary interest (such as financial gain). Financial relationships are easily identifiable, but conflicts can also occur because of personal relationships or rivalries, academic competition, or intellectual beliefs. A conflict can be actual or potential, and full disclosure to the Editor of all relationships is a requisite. Purposeful failure to disclose conflicts is a form of misconduct and might lead to publication of a correction or even to retraction. All submissions to Atena Journal of Public Health must include disclosure of all relationships in which there is a potential or actual conflict of interest, even if it not directly relevant to the submitted work. The Editor may use such information as a basis for editorial decisions and will publish all disclosures that authors declare.
Agreements between authors and study sponsors that interfere with authors’ access to all of a study’s data, or that interfere with their ability to analyse and interpret the data and to prepare and publish manuscripts independently, may represent conflicts of interest, and should be avoided. Authors may be required to provide the journal with any such agreements in confidence.
• The corresponding author must collect ICMJE Forms for Disclosure of Potential Conflicts of Interest from every author. At the end of the text, under a subheading “Conflicts of Interest”, a full and accurate statement (which includes all of the information from each author's form) must be included, disclosing any financial and personal relationships with other people or organisations, even if it does not directly relate to the submitted work. Examples of financial conflicts include employment, consultancies, stock ownership, honoraria, paid expert testimony, patents or patent applications, and travel grants, all within 3 years of beginning the work submitted. If there are no conflicts of interest, authors should state: "The authors declare no conflict of interest".
Role of the funding source
• All sources of funding should be declared as an acknowledgment at the end of the text. Authors must describe also the role of the study sponsor(s), if any, in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication
• If there is no Methods section, the role of the funding source should be stated as an acknowledgment. If the funding source had no such involvement, the authors should state this
• The corresponding author should confirm that he or she had full access to all the data in the study and had final responsibility for the decision to submit for publication
Role of medical writer or editor
• If a medical writer or editor was involved in the creation of your manuscript, we need a signed statement from the corresponding author to include their name and information about funding of this person
• This information should be added to the Acknowledgments or Contributors section
• We require signed statements from any medical writers or editors declaring that they have given permission to be named as an author, as a contributor, or in the Acknowledgments section
Patient and other consents
• Appropriate written consents, permissions, and releases must be obtained where you wish to include any case details, personal information, and/or images of patients or other individuals in Atena Journals in order to comply with all applicable laws and regulations concerning privacy and/or security of personal information. Studies on patients or volunteers need approval from an ethics committee and informed consent from participants. These should be documented in your paper.
• Do not use “blackout” bars or similar devices to anonymise patients in clinical images: if you have taken consent appropriately masking is not needed.
• Since the consent form needs to comply with the relevant legal requirements of your particular jurisdiction, we do not provide sample forms; this is your responsibility. Your affiliated institution should be able to provide an appropriate form.
• For the purposes of publishing in Atena Journals, a consent, permission, or release should include, without limitation, publication in all formats (including print, electronic, and websites), in sublicensed and reprinted versions (including translations), and in other works and products.
• To respect your patient’s and any other individual’s privacy, please do not send signed forms to Atena Journal of Public Health. Please retain copies of the signed forms in the event they should be needed.
• If consent, permission, or release is made subject to any conditions, Atena Journal of Public Health must be made aware in writing of all such conditions before publication.
Types of article and manuscript requirements
Please ensure that anything you submit to Atena Journal of Public Health follows the guidelines provided for each article type. For instruction on how to format the text of your paper, including tables, figures, and references, please see our Formatting guidelines.
• Atena Journal of Public Health prioritises reports of original research that are likely to change practice or thinking
• We require the registration of all interventional trials, whether early or late phase, in a primary register that participates in WHO’s International Clinical Trial Registry Platform or in ClinicalTrials.gov, in accord with ICMJE recommendations. We also encourage full public disclosure of the minimum 21-item trial registration dataset at the time of registration and before recruitment of the first participant. The registry must be independent of for-profit interest
• Reports of trials must conform to CONSORT 2010 guidelines and should be submitted with their protocols
• All reports of randomised trials should include a section entitled Randomisation and masking, within the Methods section.
• Cluster-randomised trials must be reported according to CONSORT extended guidelines
• Randomised trials that report harms must be described according to extended CONSORT guidelines
• Studies of diagnostic accuracy must be reported according to STARD guidelines
• Observational studies (cohort, case-control, or cross-sectional designs) must be reported according to the STROBE statement, and should be submitted with their protocols
• We encourage the registration of all observational studies on a WHO-compliant registry
• Genetic association studies must be reported according to STREGA guidelines
• Systematic reviews and meta-analyses must be reported according to PRISMA guidelines.
• Reports of studies of global health estimates should be reported according to the GATHER statement
• To find reporting guidelines see: https://www.equator-network.org/
All Articles should, as relevant:
• Include an abstract (semistructured summary), with four paragraphs (Objectives, Methods, Findings, Conclusions), not exceeding 250 words. Our electronic submission system will ask you to copy and paste this section at the “Submit Abstract” stage
• For randomised trials, the abstract should adhere to CONSORT extensions: abstracts
• When reporting Kaplan-Meier survival data, at each timepoint, authors must include numbers at risk, and are encouraged to include the number of censored patients.
• For intervention studies, the abstract should include the primary outcome expressed as the difference between groups with a confidence interval on that difference (absolute differences are more useful than relative ones). Secondary outcomes can be included as long as they are clearly marked as secondary and all such outcomes are reported
• Use the SI system of units and the recommended international non-proprietary name (rINN) for drug names. Ensure that the dose, route, and frequency of administration of any drug you mention are correct
• Use gene names approved by the Human Gene Organisation. Novel gene sequences should be deposited in a public database (GenBank, EMBL, or DDBJ), and the accession number provided. Authors of microarray papers should include in their submission the information recommended by the MIAME guidelines. Authors should also submit their experimental details to one of the publicly available databases: ArrayExpress or GEO
• Include any necessary additional data as part of your submission
• All accepted Articles should include a link to the full study protocol published on the authors’ institutional website
• We encourage researchers to enrol women and ethnic groups into clinical trials of all phases, and to plan to analyse data by sex and by race
• For all study types, we encourage correct use of the terms sex (when reporting biological factors) and gender (when reporting identity, psychosocial, or cultural factors). Where possible, report the sex and/or gender of study participants, and describe the methods used to determine sex and gender. Separate reporting of data by demographic variables, such as age and sex, facilitates pooling of data for subgroups across studies and should be routine, unless inappropriate. Discuss the influence or association of variables, such as sex and/or gender, on your findings, where appropriate, and the limitations of the data.
All submitted reports of clinical trials must contain a data sharing statement, to be included at the end of the manuscript. Data sharing statements must indicate:
• Whether data collected for the study, including individual participant data and a data dictionary defining each field in the set, will be made available to others (“undecided” is not an acceptable answer);
• What data will be made available (deidentified participant data, participant data with identifiers, data dictionary, or other specified data set);
• Whether additional, related documents will be available (eg, study protocol, statistical analysis plan, informed consent form);
• When these data will be available (beginning and end date, or “with publication”, as applicable);
• Where the data will be made available (including complete URLs or email addresses if relevant);
• By what access criteria data will be shared (including with whom, for what types of analyses, by what mechanism – eg, with or without investigator support, after approval of a proposal, with a signed data access agreement - or any additional restrictions).
Clinical trials must include a data sharing plan in the trial’s registration. If the data sharing plan changes after registration, this should be reflected in the statement submitted and published, and updated in the registry record. For reports of research other than clinical trials, data sharing statements are encouraged but not required.
• Any substantial error in any article published in Atena Journal of Public Health should be corrected as soon as possible. Blame is not apportioned; the important thing is to set the record straight.
• We will always correct any error affecting a non-proprietory drug name, dose, or unit, any numerical error in the results, or any factual error in the interpretation of results.
• Manuscripts can be submitted in English, Spanish, Italian, or Polish.
• For manuscripts submitted in Spanish, Italian, or Polish: the title, abstract and key words must be presented in both English and the language in which the manuscript is written.
• For manuscripts submitted in English: the title, abstract and key words must be presented only in English.
• Atena Journals offer Language Editing Services. For more information please contact firstname.lastname@example.org
• A brief title, author name(s), affiliation(s), and full address(es) of the authors must be included. The name and address of the corresponding author/s should be separately and clearly indicated with email details.
Formatting of text
• Type a single space at the end of each sentence
• Do not use bold face for emphasis within text
• We use a comma before the final “and” or “or” in a list of items
• Numbers one to ten are written out in words unless they are used as a unit of measurement, except in figures and tables
• Use single hard-returns to separate paragraphs. Do not use tabs or indents to start a paragraph
• Do not use the automated features of your software, such as hyphenation, endnotes, headers, or footers (especially for references).
• Cite references in the text sequentially in the Vancouver numbering style, identified by Arabic numerals in square brackets [ ], and placed before the punctuation; for example , [1–3] or [1,3]. References should follow the standards summarized in the NLM’s International Committee of Medical Journal Editors (ICMJE) Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals: Sample References webpage and detailed in the NLM’s Citing Medicine, 2nd edition.
• Two references are cited separated by a comma, with no space. Three or more consecutive references are given as a range with an en rule.
• References in tables, figures, and panels should be in numerical order according to where the item is cited in the text
• If there are six authors or fewer, give all six in the form: surname space initials comma
• If there are seven or more give the first three in the same way, followed by et al
• For a book, give any editors and the publisher, the city of publication, and year of publication
• For a chapter or section of a book, also give the authors and title of the section, and the page numbers
• For online material, please cite the URL, together with the date you accessed the website
• Online journal articles can be cited using the DOI number
• Do not put references in the Summary
• Ensuring the text in the tables is editable and all grid lines are visible.
• Do not merge cells horizontally or vertically within a table, apart from when required in column headings.
• In any cells in a row of data for which no data were collected or available, please either insert two mid-dots (··), NA (not applicable, to be included as an abbreviation in the footnotes), or suitable filler text.
• Tables should not have multiple parts (eg, A, B, etc); the column headings at the top of the table should apply to the entire table
• Do not use soft returns within a cell; if you wish text or data to be presented on a separate line, it must be in a new row below.
• Table titles should be concise and descriptive, and legends and footnotes should be used to give additional information needed to understand the data; please list and spell out all abbreviations in the table and list any footnotes.
• For images (photographs or photographic images) that are used as part of illustration or image composite figures we require a file that is no less than 300 dpi when set at its final printed size. Ideal file formats are TIF or JPG
• For illustrations (all non-photographic line-work and general drawing) we require editable vector files that contain selectable geometry and fonts (editable text). The editability of files depends on the package they were created in, but as a rule we would prefer to receive any of the following: Adobe Illustrator (.ai) file; Adobe Illustrator or generic .eps files exported from a graphics program; vector-based PDF, PowerPoint, or Word file; or SVG file. When files are exported to eps files, we would prefer text to be exported “as text” rather than “as objects”, which is especially crucial for files such as forest plots in which there is a lot of text
• Images that have been published previously should be accompanied by a statement indicating permission to reproduce the image. If you have used previously published images, you must obtain permission from the copyright holder of the paper, which might be the authors or the publisher. If all the figures are your own and have not been published before, then this requirement does not apply.
GUIDELINES FOR SUPPLEMENTARY MATERIAL
Material will be published at the discretion of Atena Journals’ editors. All material should be provided in English.
• Main heading for the web extra material should be in 12 point Times New Roman font BOLD
• Text should be in 10 point Times New Roman font, single spaced
• Headings should be in 10 point BOLD
• Main table heading should be in 10 point Times New Roman font BOLD
• Legends should be in 10 point, single spaced
• Tables should be in 10 point Times New Roman font, single spaced
• Headings within tables should be in 10 point BOLD
• SI units are required
• Numbers in text and tables should always be provided if % is shown
• Means should be accompanied by SDs, and medians by IQR
• p values should be given to two significant figures, unless p<0.0001
• Recommended international non-proprietary name (rINN) is required
• We encourage use of neuroscience-based nomenclature for psychotropic drugs
• Vancouver style
• Numbered in order of mention in appendix and numbered separately from references in the full paper
• All images must have a minimum resolution of 300 dpi, width 107 mm
• Main figure heading should be in 10 point Times New Roman font BOLD
• Legends should be in 10 point, single spaced
DISCLOSURE OF RESULTS BEFORE PUBLICATION
• Presentation of data at a scientific meeting, as a poster, abstract, orally, on a CD, or as an abstract on the web, or on a preprint server does not conflict with submission to Atena Journals. Atena Journal of Public Health does not regard results that are posted in the same clinical trials registry in which primary registration resides as a previous publication, if the results are presented in the form of a brief structured abstract or table
• Atena Journal of Public Health publishes papers online as they become ready.
HOW ATENA JOURNAL OF PUBLIC HEALTH HANDLES YOUR PAPER
• Receipt of your paper will be acknowledged by an email containing a reference number, which should be used in all future communications
Checking for plagiarism, duplicate publication, and text recycling
• At our discretion, material that we are interested in publishing will be checked by editors using CrossCheck. We expect that such papers are written in a way that offers new thinking without recycling previously published text.
Single-blind peer review
• Every paper published in Atena Journal of Public Health has been peer reviewed.
• On submission to Atena Journal of Public Health, your report will first be read by one or more of the journal’s staff of physicians and scientists. This is an important feature of our selection process and many papers are turned away on the basis of in-house assessment alone. That decision will be communicated quickly.
• Papers are followed by single-blind peer review by at least three external reviewers. You will receive notification of which editor is handling the peer review of your paper.
• Submissions that survive in-house and peer review might be referred back to authors for revision. This is an invitation to present the best possible paper for further scrutiny by the journal; it is not an acceptance
• Authors should give priority to such revisions; the journal will reciprocate by making a final decision quickly
• The revised version should be sent back, and it should be highlighted in a different colour to show where changes have been made. Detailed responses to reviewers’ comments, in a covering letter, are also necessary
• Sometimes editors make mistakes. When we do, we like to hear about them. If an author believes that an editor has made an error in declining a paper, we welcome an appeal. In your appeal letter, which should be sent to email@example.com, please state why you think the decision is mistaken, and set out your specific responses to any peer reviewers’ comments if those seem to have been the main cause of rejection
• At least two editors will decide whether to invite a revised manuscript and whether re-review, or otherwise, is indicated
• Atena Journals employ highly skilled Editors, and it is likely that your paper will be substantially edited after acceptance to ensure that it is accurate, clear, and understandable to a wide readership
• You will receive a proof from an Editor. That proof should be corrected and returned within 48 h
• We are keen to better understand and improve editorial conduct, decision making, and issues related to peer review.
Therefore, we occasionally take part in or conduct editorial research. Your submitted paper might be used in such
research. If you do not want your paper entered into such a study, please let us know in your covering letter. Your decision
to take part or not will have no effect on the editorial decision on your paper
OPEN ACCESS POLICY
Article processing charges
• No subscription or pay-per-view charges apply to any content published in Atena Journal of Public Health.
• The journal charges no article processing fee.
For all articles published in Atena Journals, copyright is retained by the authors. Articles are licensed under an open access Creative Commons CC BY 4.0 license, meaning that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. These conditions allow for maximum use and exposure of the work, while ensuring that the authors receive proper credit. It is also understood that the opinions expressed in the articles do not necessarily represent the opinions and scientific policies of Atena Journals, the authors being exclusively responsible for them.
WHAT HAPPENS AFTER PUBLICATION?
Press releases are issued by Atena Journals’ press office for selected content published in our journals. You will be advised in advance if your paper has been selected for press release. Atena Journals’ media relations team will contact you with detailed instructions about it. If your institution would like to issue a press release for your paper, please inform firstname.lastname@example.org
Authors may be required to provide the raw data for research papers when they are under review and up to 10 years after publication in Atena Journal of Public Health.
Atena Journals support responsible sharing. We recognise that authors want to share their papers and we encourage this.
When reporting on research that involves human subjects, human material, human tissues, or human data, authors must declare that the investigations were carried out following the rules of the Declaration of Helsinki of 1975 (https://www.wma.net/what-we-do/medical-ethics/declaration-of-helsinki/), revised in 2013. According to point 23 of this declaration, an approval from an ethics committee should have been obtained before undertaking the research. At a minimum, a statement including the project identification code, date of approval, and name of the ethics committee or institutional review board should be cited in the Methods Section of the article. Data relating to individual participants must be described in detail, but private information identifying participants need not be included unless the identifiable materials are of relevance to the research (for example, photographs of participants’ faces that show a particular symptom). Editors reserve the right to reject any submission that does not meet these requirements.
Example of an ethical statement: "All participants gave their informed consent for inclusion before they participated in the study. The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Ethics Committee of XXX (Project identification code)."
A written informed consent for publication must be obtained from participating patients who can be identified (including by the patients themselves). Patients’ initials or other personal identifiers must not appear in any images. For manuscripts that include any case details, personal information, and/or images of patients, authors must obtain signed informed consent from patients (or their relatives/guardians) before submitting to an MDPI journal. Patient details must be anonymized as far as possible, e.g., do not mention specific age, ethnicity, or occupation where they are not relevant to the conclusions.
Alternatively, you may provide a detailed justification of why informed consent is not necessary. For the purposes of publishing in Atena Journals, a consent, permission, or release form should include unlimited permission for publication in all formats (including print, electronic, and online), in sublicensed and reprinted versions (including translations and derived works), and in other works and products under open access license. To respect patients’ and any other individual’s privacy, please do not send signed forms. The journal reserves the right to ask authors to provide signed forms if necessary.
The editors will require that the benefits potentially derived from any research causing harm to animals are significant in relation to any cost endured by animals, and that procedures followed are unlikely to cause offense to the majority of readers. Authors should particularly ensure that their research complies with the commonly-accepted '3Rs':
Any experimental work must also have been conducted in accordance with relevant national legislation on the use of animals for research. For further guidance authors should refer to the Code of Practice for the Housing and Care of Animals Used in Scientific Procedures.
Manuscripts containing original descriptions of research conducted in experimental animals must contain details of approval by a properly constituted research ethics committee. As a minimum, the project identification code, date of approval and name of the ethics committee or institutional review board should be cited in the Methods section.
Atena Journals endorse the ARRIVE guidelines (www.nc3rs.org.uk/ARRIVE) for reporting experiments using live animals. Authors and reviewers can use the ARRIVE guidelines as a checklist, which can be found at www.nc3rs.org.uk/ARRIVEchecklist.
Methods sections for submissions reporting on research with cell lines should state the origin of any cell lines. For established cell lines the provenance should be stated and references must also be given to either a published paper or to a commercial source. If previously unpublished de novo cell lines were used, including those gifted from another laboratory, details of institutional review board or ethics committee approval must be given, and confirmation of written informed consent must be provided if the line is of human origin.
Experimental research on plants (either cultivated or wild) including collection of plant material, must comply with institutional, national, or international guidelines. We recommend that authors comply with the Convention on Biological Diversity and the Convention on the Trade in Endangered Species of Wild Fauna and Flora.
For each submitted manuscript supporting genetic information and origin must be provided. For research manuscripts involving rare and non-model plants, voucher specimens must be deposited in an accessible herbarium or museum. Vouchers may be requested for review by future investigators to verify the identity of the material used in the study (especially if taxonomic rearrangements occur in the future). They should include details of the populations sampled on the site of collection (GPS coordinates), date of collection, and document the part(s) used in the study where appropriate. For rare, threatened or endangered species this can be waived but it is necessary for the author to describe this in the cover letter.
Editors reserve the rights to reject any submission that does not meet these requirements.
Atena Journals support the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, issued by the International Committee of Medical Journal Editors (ICMJE Recommendations), and the Committee on Publication Ethics (COPE) Core Practices. We follow COPE’s guidelines.
The editors of this journal enforce a rigorous peer-review process together with strict ethical policies and standards to ensure to add high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification, image manipulation, inappropriate authorship credit, and the like, do arise. The editors of Atena Journals take such publishing ethics issues very seriously and are trained to proceed in such cases with a zero tolerance policy.
Authors wishing to publish their papers in Atena Journals must abide to the following:
Plagiarism includes copying text, ideas, images, or data from another source, even from your own publications, without giving any credit to the original source.
Reuse of text that is copied from another source must be between quotes and the original source must be cited. If a study's design or the manuscript's structure or language has been inspired by previous works, these works must be explicitly cited.
If plagiarism is detected during the peer review process, the manuscript may be rejected. If plagiarism is detected after publication, we may publish a correction or retract the paper.
Irregular manipulation includes: 1) introduction, enhancement, moving, or removing features from the original image; 2) grouping of images that should obviously be presented separately; or 3) modifying the contrast, brightness or color balance to obscure, eliminate or enhance some information.
If irregular image manipulation is identified and confirmed during the peer review process, we may reject the manuscript. If irregular image manipulation is identified and confirmed after publication, we may correct or retract the paper.
Our editors will investigate any allegations of publication misconduct and may contact the authors' institutions or funders if necessary. If evidence of misconduct is found, appropriate action will be taken to correct or retract the publication. Authors are expected to comply with the best ethical publication practices when publishing with Atena Journals.
For all articles published in Atena Journals, copyright is retained by the authors. Articles are licensed under an open access Creative Commons CC BY 4.0 license, meaning that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. These conditions allow for maximum use and exposure of the work, while ensuring that the authors receive proper credit.
It is absolutely essential that authors obtain permission to reproduce any published material (figures, schemes, tables or any extract of a text) which does not fall into the public domain, or for which they do not hold the copyright. Permission should be requested by the authors from the copyrightholder (usually the Publisher, please refer to the imprint of the individual publications to identify the copyrightholder).
Permission is required for:
Permission is not required for:
In order to avoid unnecessary delays in the publication process, you should start obtaining permissions as early as possible. If in any doubt about the copyright, apply for permission. Atena Journals cannot publish material from other publications without permission.
The copyright holder may give you instructions on the form of acknowledgement to be followed; otherwise follow the style: "Reproduced with permission from [author], [book/journal title]; published by [publisher], [year].' at the end of the caption of the Table, Figure or Scheme.
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.